Published online before print October 2, 2006, doi: 10.1161/CIRCULATIONAHA.105.610642
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:1572-1580.)
© 2006 American Heart Association, Inc.
Heart Failure |
Drawbacks and Prognostic Value of Formulas Estimating Renal Function in Patients With Chronic Heart Failure and Systolic Dysfunction
From the Departments of Cardiology (T.D.J.S, D.J.v.V., A.A.V., H.L.H.) and Nephrology (G.N.), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Correspondence to Dr H.L. Hillege, Department of Cardiology, Thoraxcenter, University Medical Center Groningen, Hanzeplein 1, PO Box 30001, 9700 RB Groningen, The Netherlands. E-mail J.L.Hillege{at}tcc.umcg.nl
Received December 28, 2005; revision received August 1, 2006; accepted August 4, 2006.
Background— Renal function is an important risk marker for morbidity and mortality in chronic heart failure (CHF) and is often estimated with the use of creatinine-based formulas. However, these formulas have never been validated in a wide range of CHF patients. We validated 3 commonly used formulas estimating glomerular filtration rate (GFR) with true GFR in CHF patients. Furthermore, we compared the prognostic value of these formulas for cardiovascular outcome with that of true GFR during 12 months of follow-up.
Methods and Results— In 110 CHF patients (age, 57±11.7 years; left ventricular ejection fraction, 0.27±0.09; NYHA class, 2.5±0.9), we measured 125I-iothalamate clearance. Cockcroft-Gault (GFRcg), Modification of Diet in Renal Disease (MDRD), and simplified MDRD (sMDRD) equations were used as creatinine-based renal function estimations. Furthermore, 24-hour creatinine clearance (CrCl) was determined. CrCl and GFRcg were the most accurate. MDRD was most precise formula, although it was also highly biased. All formulas overestimated in the lower ranges and underestimated in the upper ranges of the GFR corrected for body surface area. The predictive performance of the formulas was best in severe CHF (NYHA classes III and IV). The prognostic value of CrCl and MDRD for cardiovascular outcome was comparable to that of GFR, the sMDRD was slightly less, and the GFRcg had a significantly worse prognostic value.
Conclusions— In the more severe ranges of CHF, creatinine-based formulas and CrCl corrected for body surface area appeared to be more precise and accurate in estimating true GFR corrected for body surface area. The MDRD formula is the most precise and has a good prognostic value, whereas the sMDRD is slightly less accurate but uses fewer parameters, which makes this formula a practical alternative in clinical practice.
CLINICAL PERSPECTIVE
Related Article:
-
Issue Highlights
Circulation 2006 114: 1555.[Full Text]
This article has been cited by other articles:
 |
|
 |
|
  P. van der Meer, D. J. Lok, J. L. Januzzi, P. W. B.-A. de la Porte, E. Lipsic, J. van Wijngaarden, A. A. Voors, W. H. van Gilst, and D. J. van Veldhuisen Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients Eur. Heart J., June 2, 2008; 29(12): 1510 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Loef, R. H. Henning, G. Navis, A. J. Rankin, W. van Oeveren, T. Ebels, and A. H. Epema Changes in glomerular filtration rate after cardiac surgery with cardiopulmonary bypass in patients with mild preoperative renal dysfunction Br. J. Anaesth., June 1, 2008; 100(6): 759 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Q. Khan, O. Dhillon, D. Kelly, I. B. Squire, J. Struck, P. Quinn, N. G. Morgenthaler, A. Bergmann, J. E. Davies, and L. L. Ng Plasma N-Terminal B-Type Natriuretic Peptide as an Indicator of Long-Term Survival After Acute Myocardial Infarction: Comparison With Plasma Midregional Pro-Atrial Natriuretic Peptide: The LAMP (Leicester Acute Myocardial Infarction Peptide) Study J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1857 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. SMIT, J. W. L. HARTOG, A. A. VOORS, and D. J. VAN VELDHUISEN Advanced Glycation Endproducts in Chronic Heart Failure Ann. N.Y. Acad. Sci., April 1, 2008; 1126(1): 225 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Melloni, E. D. Peterson, A. Y. Chen, L. A. Szczech, L. K. Newby, R. A. Harrington, W. B. Gibler, E. M. Ohman, S. A. Spinler, M. T. Roe, et al. Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 991 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W.L. Hartog, A. A. Voors, C. G. Schalkwijk, J. Scheijen, T. D.J. Smilde, K. Damman, S. J.L. Bakker, A. J. Smit, and D. J. van Veldhuisen Clinical and prognostic value of advanced glycation end-products in chronic heart failure Eur. Heart J., December 1, 2007; 28(23): 2879 - 2885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schou, F. Gustafsson, C. N. Kistorp, P. Corell, A. Kjaer, and P. R. Hildebrandt Effects of Body Mass Index and Age on N-Terminal Pro Brain Natriuretic Peptide Are Associated with Glomerular Filtration Rate in Chronic Heart Failure Patients Clin. Chem., November 1, 2007; 53(11): 1928 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Q. Khan, O. S. Dhillon, R. J. O'Brien, J. Struck, P. A. Quinn, N. G. Morgenthaler, I. B. Squire, J. E. Davies, A. Bergmann, and L. L. Ng C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial Infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study Circulation, April 24, 2007; 115(16): 2103 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Delanaye, J. M. Krzesinski, and E. Cavalier Letter by Delanaye et al Regarding Article, "Drawbacks and Prognostic Value of Formulas Estimating Renal Function in Patients With Chronic Heart Failure and Systolic Dysfunction" Circulation, March 20, 2007; 115(11): e333 - e333. [Full Text] [PDF]
|
|